MicroRNA-384 represses the growth and invasion of non-small-cell lung cancer by targeting astrocyte elevated gene-1/Wnt signaling
2017 · Biomedicine & Pharmacotherapy · 33 citations
https://doi.org/10.1016/j.biopha.2017.08.143
J
Jie Feng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
156
Papers
3.8K
Citations
28
h-index
66
i10-index
Jie Feng is an academic researcher from Shanghai University of Sport. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Pharmacological Effects and Toxicity Studies & Epilepsy research and treatment. The author has an h-index of 28, co-authored 133 publications.
ORCID: 0009-0008-6338-5178Papers by this author
worksEfficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
2022 · BMC Complementary Medicine and Therapies · 25 citations
https://doi.org/10.1186/s12906-022-03740-9
Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small-Cell Lung Cancer
2022 · American Journal of Respiratory and Critical Care Medicine · 23 citations
https://doi.org/10.1164/rccm.202110-2358oc
Foxk1 and Foxk2 promote cardiomyocyte proliferation and heart regeneration
2025 · Nature Communications · 13 citations
https://doi.org/10.1038/s41467-025-57996-z
Impact of ABCC2 1249G>A and −24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China
2022 · Therapeutic Drug Monitoring · 11 citations
https://doi.org/10.1097/ftd.0000000000001003
Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world study
2023 · BMC Pediatrics · 8 citations
https://doi.org/10.1186/s12887-023-04039-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat